FDA approves Pfizer lung cancer drug
NEW YORK — The Food and Drug Administration has approved a new cancer drug made by Pfizer, the drug maker said.
The FDA approved Pfizer’s Xalkori (crizotinib) capsules, a treatment for patients with non-small cell lung cancer that has advanced locally or spread to other parts of the body, also known as metastasis. The drug specifically is designed to target NSCLC containing the enzyme anaplastic lymphoma kinase, as determined by a companion test also approved by the FDA.
"Overall, lung cancer is responsible for more deaths each year worldwide than any other type of cancer," Pfizer president and CEO Ian Read said. "Xalkori is an advance in the treatment of this devastating illness, providing a new therapeutic option for a subset of patients with the disease."
Iams Naturals gets a boost with two new products
MASON, Ohio — Procter & Gamble announced that its Iams pet food brand has launched two new Iams Naturals products.
Iams Naturals, which launched in 2007, now features sensitive naturals and simple and natural formulas, the company said. To mark the launch, Iams has debuted two television commercials to underscore the expansion of the line that feature a "spokesdog" named Spike.
Iams Naturals recipes are available at pet specialty stores, mass retailers and grocers nationwide. For more information, click here.
CVS Caremark’s new chapter continues with appointment of CVS/pharmacy president
WHAT IT MEANS AND WHY IT’S IMPORTANT — The news that CVS Caremark has appointed a new president of CVS/pharmacy, Mark Cosby, is yet one more page in the new chapter for the Woonsocket, R.I.-based powerhouse.
(THE NEWS: CVS Caremark names new president of CVS/pharmacy. For the full story, click here)
As the article states, Cosby succeeds Larry Merlo, who led the company’s retail business prior to taking the helm as CEO of CVS Caremark in March.
What’s interesting to note is that Cosby, a retail executive who most recently served as president of Macy’s, is known as an innovator. While he was serving as COO of KFC, he initiated the co-branded stores with two eateries under the same roof. That tactic now is widespread within the fast food industry. Cosby also is credited with being the brains behind KFC’s popular popcorn chicken.
It will be interesting to see how Cosby’s insight and innovative spirit will play out within retail pharmacy.
There’s no doubt industry observers will be watching as the new chapter for CVS Caremark continues to unfold, and the company further positions itself along to the frontlines of health care.